A
Anavex Life Sciences Corp. (AVXL)
NMS – Real Time Price. Currency in USD
3.41
-0.10 (-2.85%)
At close: Aug 12, 2026, 4:00 PM EDT
3.39
-0.02 (-0.70%)
After-hours: Aug 12, 2026, 5:54 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
3.41
-0.10 (-2.85%)
At close: Aug 12, 2026, 4:00 PM EDT
3.39
-0.02 (-0.70%)
After-hours: Aug 12, 2026, 5:54 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $127.4M barely cover the upcoming debt maturities $0.0
Total current assets $128.8M exceed Total current liabilities $7.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 18.24 | 6.05 | 10 | |
| Quick ratio | N/A | 5.63 | 1.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | N/A | 1.04 | 1.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 2.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -51M | -56M | -53M | -51M | -39M |
| Net Income | -48M | -48M | -43M | -46M | -34M |
| EBITDA | -51M | -56M | -53M | -51M | -32M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 50 | 5.5 |
| Next quarter | N/A | 0 | 1.0 |
| Current year | N/A | 38.89 | 5.5 |
| Next year | 55.93 | -66.67 | 5.5 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 6.04 | 0 | 16.89 | 6.3 |
| Y/Y | 999 | 52.32 | 53.85 | 41 | 10 |
| 3y average | 999 | 0.88 | 4.24 | -17.39 | 4.3 |
| 5y average | 999 | -13.62 | -4.4 | -14.93 | 3.3 |
| Weighted average score | 6.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |